HCoV-229E-IN-1

HCoV-229E-IN-1

• CAS Number: 2639757-13-2
• UNSPSC Description: HCoV-229E-IN-1 is a potent inhibitor of HCoV-229E replication, with an EC50 of 0.65 μM and 0.6 μM in MTS and CPE cells, respectively[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/hcov-229e-in-1.html
• Purity: 99.16
• Solubility: DMSO : 12.5 mg/mL (ultrasonic)
• Smiles: C=C([C@@H]1CC[C@@]2(CC[C@]3([C@@]4(CC[C@]5(C(C)(C6=C(C[C@@]5([C@]4(CC[C@@]3([C@]21[H])[H])[H])C)N=NN6[C@H](C7=CC=CC=C7)C)C)[H])C)C)C(O)=O)C
• Molecular Weight: 583.85
• References & Citations: [1]Stevaert A, et, al. Betulonic Acid Derivatives Interfering with Human Coronavirus 229E Replication via the nsp15 Endoribonuclease. J Med Chem. 2021 May 13;64(9):5632-5644.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: No Development Reported